Skip to main content

CSF N-Glycomics Using MALDI MS Techniques in Alzheimer’s Disease

  • Protocol
  • First Online:

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1750))

Abstract

In this chapter, we present the methodology currently applied in our laboratory for the structural elucidation of the cerebrospinal fluid (CSF) N-glycome. N-glycans are released from denatured carboxymethylated glycoproteins by digestion with peptide-N-glycosidase F (PNGase F) and purified using both C18 Sep-Pak® and porous graphitized carbon (PGC) HyperSep™ Hypercarb™ solid-phase extraction (SPE) cartridges. The glycan pool is subsequently permethylated to increase mass spectrometry sensitivity. Molecular assignments are performed through matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI TOF MS) analysis considering either the protein N-linked glycosylation pathway or MALDI TOF MS/MS data. Each stage has been optimized to obtain high-quality mass spectra in reflector mode with an optimal signal-to-noise ratio up to m/z 4800. This method has been successfully adopted to associate specific N-glycome profiles to the early and the advanced phases of Alzheimer’s disease.

This is a preview of subscription content, log in via an institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Schedin-Weiss S, Winblad B, Tjernberg LO (2014) The role of protein glycosylation in Alzheimer disease. FEBS J 281:46–62

    Article  CAS  PubMed  Google Scholar 

  2. Palmigiano A, Barone R, Sturiale L et al (2016) CSF N-glycoproteomics for early diagnosis in Alzheimer’s disease. J Proteome 131:29–37

    Article  CAS  Google Scholar 

  3. Barone R, Sturiale L, Palmigiano A et al (2012) Glycomics of pediatric and adulthood diseases of the central nervous system. J Proteome 75:5123–5139

    Article  CAS  Google Scholar 

  4. Kizuka Y, Kitazume S, Fujinawa R, Saito T, Iwata N, Saito T et al (2015) An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer’s disease. EMBO Mol Med 7:175–189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kizuka Y, Nakano M, Kitazume S, Saito T et al (2016) Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions. Biochem J 473(1):21–30

    Article  CAS  PubMed  Google Scholar 

  6. Kizuka Y, Kitazume S, Taniguchi N (2017) N-glycan and Alzheimer’s disease. Biochim Biophys Acta 1861(10):2447–2454. https://doi.org/10.1016/j.bbagen.2017.04.012

    Article  PubMed  CAS  Google Scholar 

  7. Stanley P, Schachter H, Taniguchi N (2009) N-glycans. In: Varki A, Cummings R, Esko J, Freeze H, Stanley P, Bertozzi CR, Hart GW, Etzler ME (eds) Essentials of glycobiology, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY

    Google Scholar 

  8. Hoffmann A, Nimtz M, Getzlaff R, Conradt HS (1995) ‘Brain-type’ N-glycosylation of asialo-transferrin from human cerebrospinal fluid. FEBS Lett 359(2–3):164–168

    Article  CAS  PubMed  Google Scholar 

  9. Royle LI, Campbell MP, Radcliffe CM, White DM, Harvey DJ et al (2008) HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem 376:1–12

    Article  CAS  PubMed  Google Scholar 

  10. Domon B, Costello CE (1988) A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj J 5:397–409

    Article  CAS  Google Scholar 

  11. Schachter H (1986) Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem Cell Biol 64(3):163–181

    Article  CAS  PubMed  Google Scholar 

  12. Akasaka-Manya K, Manya H, Sakurai Y et al (2010) Protective effect of N-glycan bisecting GlcNAc residues on β-amyloid production in Alzheimer’s disease. Glycobiology 20(1):99–106

    Article  CAS  PubMed  Google Scholar 

  13. Avagyan H, Goldenson B, Tse E, Masoumi A et al (2009) Immune blood biomarkers of Alzheimer disease patients. J Neuroimmunol 210:67–72

    Article  CAS  PubMed  Google Scholar 

  14. Ikeda Y, Ihara H, Tsukamoto H et al (2014) Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase (MGAT3); β1,4-N-acetylglucosaminyltransferase III (GnT-III, GlcNAcT-III). In: Taniguchi N et al (eds) Handbook of glycosyltransferase and related genes, 2nd edn. Springer, Tokyo

    Google Scholar 

  15. Ciucanu I, Kerek F (1984) A simple and rapid method for the permethylation of carbohydrates. Carbohydr Res 131:209–217

    Article  CAS  Google Scholar 

  16. Ceroni A, Maass K, Geyer H, Geyer R, Dell A, Haslam SM (2008) GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res 7:1650–1659

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Generous donation from Stellalucente Trust is gratefully acknowledged. This chapter is dedicated to our dear friend and colleague Francesco Le Pira, University of Catania, who too early passed away.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Domenico Garozzo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Palmigiano, A. et al. (2018). CSF N-Glycomics Using MALDI MS Techniques in Alzheimer’s Disease. In: Perneczky, R. (eds) Biomarkers for Alzheimer’s Disease Drug Development. Methods in Molecular Biology, vol 1750. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7704-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7704-8_5

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7703-1

  • Online ISBN: 978-1-4939-7704-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics